Healthcare at Home Launches Sciensus Rare to Connect Emerging Biotech and Large Pharma Companies With Rare Disease Patients in Europe and Beyond
Healthcare at Home today unveils a dedicated new rare disease medicines services business: Sciensus Rare.
Sciensus Rare launches with two main aims: to ensure that patients and their families have access to the rare disease medicines and care they need, and to help biotech and pharmaceutical companies safely launch and efficiently deliver vital medication, no matter where a patient lives or the regulatory governance of that country.
The business will continue to help emerging, mid-sized, and major biotech and pharmaceutical companies gain market access in Europe and beyond, expanding Healthcare at Home’s existing rare disease and orphan medicines services further geographically and by therapy area, across five main services:
- Clinical trials in the home
- Medicines access
- Bespoke supply chain management
- Patient and family support
- Outcome monitoring in the home
According to Eurostat, the market for rare disease pharmaceutical medicines services is expected to more than double in size over the next few years, growing from €1.6bn in 2018 to €3.3bn in 2025, as the number of products requiring more complex services to support them grows. Sciensus Rare aims to meet the growing demand by creating a unique, science-led approach to help pharmaceutical partners reduce time to market for innovative, high cost, new medicines in a rapidly changing marketplace, helping to eliminate unnecessary costs and inefficiencies in the drug development process.
Gareth Williams, President of Sciensus Rare, said:
“The global pandemic has accelerated the need for bespoke patient-centred services which are required for products in drug development and commercial phases as many rare disease patients can’t or won’t travel long distances to take part in clinical trials away from home.
“Our aim is to help emerging biotech firms which have a strong presence in their home market but little or no international distribution or commercial infrastructure, as well as the established pharma companies seeking access to treatment for patients with unmet needs”.
Sciensus Rare’s services build on Healthcare at Home’s three decades of experience in treating rare disease patients. In that time, the business has treated more than 52,000 patients at home, and collaborated with over 20 rare disease pharmaceutical companies and over 4,000 healthcare providers in mainland Europe. BioMarin, which specialises in developing and commercialising biopharmaceuticals for rare diseases driven by genetic causes, has been working with Healthcare at Home since 2006 and now sees a quarter of its global sales delivered through this model.
Guy Eggleton, Executive Director Sales and Marketing Operations EUMEA, at BioMarin, said:
“Sciensus Rare has tremendous potential to build on its significant experience in rare diseases to become the global expert in helping businesses like ours connect rare disease patients and healthcare providers with effective, innovative new treatments for rare conditions.”
The need to develop and provide access to safe, effective medicines is most acute in rare diseases, many of which are genetic and affect younger patients.
“The ‘one size fits all’ approach to rare and orphan managed medication services, with no clear integrator of drug development through to commercial services is now outmoded and redundant. With many new therapies coming to market from a burgeoning pharmaceutical research and development side, it is clear to us that there is a role for a different kind of bespoke managed pharmaceutical services provider that puts the needs of the patient at its heart regardless of where the therapy is in its lifecycle.”
The Sciensus Rare name will replace Healthcare at Home’s Rare Disease Medicines Service.
** ENDS **
NOTES TO EDITORS
About Sciensus Rare ( www.sciensusrare.com)
We believe in making sure every family has access to rare disease medicines and the care they need. No matter where a patient lives or the regulatory governance of that country, we can safely launch and efficiently deliver vital medication and clinical services for families that need it most.
Joshua Vine-Lott at Aurora Healthcare Communications:
+44 (0)7543 222 552
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Telefonica UK (O2) and IDEMIA Working to Securely Connect 23 Million Homes in the UK With Smart Meters By 20253.12.2020 12:30:00 EET | Press release
O2 in partnership with IDEMIA, the global leader in Augmented Identity, has today supplied secure connectivity to over 4 million UK homes with a second generation Smart Meter. The rollout will continue into the future, supporting the UK government program to deploy Smart Meters for all UK households and small businesses. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201203005370/en/ (Photo: Business Wire) As part of the transition to a flexible energy market that requires a low carbon economy and sustainable consumption habits, smart meters give consumers near real-time information on energy helping them to take control of their energy usage and bring an end to estimated billing. Smart meters come with in-home displays to enable consumers to have a better understanding of their energy usage. Against that backdrop, customers using the latest generation of smart meters are reporting an average saving of around 10% per month.
Measuring What Matters: A New Approach to Assessing Sovereign Climate Risk3.12.2020 11:23:00 EET | Press release
Moody’s affiliate Four Twenty Seven today released a report analyzing the future exposure of the global population, the economy, and agriculture to a range of climate hazards, exploring both global trends and findings by country. Leveraging new analytics developed by Four Twenty Seven, the report assesses exposure to floods, heat stress, hurricanes and typhoons, rising sea levels, wildfires, and water stress and is based on the only known global dataset matching physical climate risk exposure to population location, GDP Purchasing Power Parity (PPP), and agricultural areas within countries. “This novel dataset provides a detailed view of the exposure of key human and economic assets around the world. Understanding exposure is critical for investors and credit institutions to price climate risk, but also to help direct finance flows towards adaptation and resilience where they’re most needed,” says Emilie Mazzacurati, Global Head of Moody’s Climate Solutions in Moody’s ESG Solutions Gro
PMI Commits to Disability Inclusion by Joining The Valuable 5003.12.2020 11:05:00 EET | Press release
Philip Morris International Inc.(PMI) (NYSE: PM) today announced that CEO André Calantzopoulos has joined The Valuable 500—a global movement putting disability inclusion on the business leadership agenda. Signing on to this initiative marks another significant step in PMI’s journey of advancing inclusion and diversity in the workplace. André Calantzopoulos said: “Businesses with a global operating footprint, such as PMI, can make a meaningful impact by ensuring that everyone—including individuals with a disability—can prosper in the workplace. By signing The Valuable 500, I am proud to join forces with a host of other CEOs who are challenging their organizations and the business world to broaden the focus of their inclusion and diversity efforts, and to help create a more inclusive world for the 1.3 billion people with disabilities. This is the right thing to do as part of our broader work to create a more equitable society. And it is also the smart thing to do, allowing PMI to tap int
Siemens Smart Infrastructure Chooses AWS as Its Preferred Cloud Provider for SAP Environments3.12.2020 11:01:00 EET | Press release
Today, Amazon Web Services (AWS), an Amazon.com company (NASDAQ: AMZN), announced that Siemens Smart Infrastructure, a business of the Siemens AG group focusing on energy distribution and intelligent buildings, is moving its SAP infrastructure to AWS. The business will migrate over 20 Enterprise Resource Planning (ERP) and Supply Chain Management (SCM) systems, based on SAP HANA, to AWS before the end of 2021. These systems support business-critical processes in areas such as manufacturing, operations, and sales across different business units including Building Products, Electrical Products, Digital Grid, and Distribution Systems. Moving these workloads to AWS will enable Siemens Smart Infrastructure to significantly shorten hardware refresh cycles, increase agility to test and deploy new systems, and provide the foundation for the company’s future transformation using SAP S/4HANA technology. This is the first migration of production-scale SAP systems to the cloud across the Siemens A
ADVA and 6WIND deliver complete uCPE solution with high-performance routing3.12.2020 11:00:00 EET | Press release
ADVA (FSE) today announced a partnership with 6WIND to deliver a high-performance and lightweight uCPE solution. Built on ADVA’s Ensemble Connector and including 6WIND routing technology, the offering provides communication service providers (CSPs) and enterprises with a complete uCPE platform. Now customers can deploy a comprehensive access solution optimized for edge cloud architecture that offers new levels of efficiency as well as future-proof scalability. The joint solution has already been selected by the German CSP WiTCOM to power its edge cloud smart city initiative, enabling services including IoT, traffic control and surveillance. “We’re joining forces with ADVA to build on our industry-leading position in uCPE. The partnership augments our current uCPE infrastructure offering with targeted applications that focus on providing complete, end-to-end networking and hosting capabilities,” said Julien Dahan, CEO, 6WIND. “With the embedding of our high-performance, ready-to-use sof
ESI Contributes to Nissan’s Breakthrough in Carbon Fiber Parts Production for Safer and Lighter Vehicles3.12.2020 10:15:00 EET | Press release
ESI Group (Paris:ESI), global player in Virtual Prototyping software and services for industry, supports Nissan Motor Co in its production process that speeds up the development of car parts made from carbon fiber reinforced plastics (CFRP). Light yet extremely strong, this material will be used to make safer and more fuel-efficient cars. Safety, comfort and autonomy are key outcomes for consumers. To face this situation, automakers continuously innovate in different fields such as lightweight to help them achieve their expected results. For this purpose, the use of new materials can be key. Commonly used in other industries such as Aerospace and with promising capabilities, Carbon Fiber Reinforced Plastics (CFRP) were too time-consuming and too expensive to industrialize for the Automotive sector. “We have always considered CFRP as a material for future generations of cars. But when it comes to reality, CFRP can be used only for limited models and appears to be more challenging for ma
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom